BioScience Health Innovations Inc.
About BioScience Health Innovations Inc. BioScience Health Innovations, Inc. engages in developing and distributing preventative health, wellness, and consumer biotech products. Its products include ...
Model output · Signal date 2026-10-16
Bioscience Health Innovations, Inc. (BHIC) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
Rating · 90D
Alpha
90-day forecast
Sign up free to reveal
30-day forecast
Alpha
Rank in coverage
Middle 30%
of 5184 stocks scored
Rank correlation · 90D
25.0%
Spearman, 357 dates
Market Cap
$80M
small-cap · #53 of 60 peers
Summary
Bioscience Health Innovations, Inc. (BHIC) stock forecast summary
On Oct. 16, 2026, BHIC is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5184 stocks scored that day.
Bioscience Health Innovations, Inc. is a small-cap company with a market capitalization of $80M. It ranks number 53 by market capitalization among the 60 Services-Computer Processing & Data Preparation issuers in our coverage with a current forecast.
For BHIC, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 25.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 32.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, BHIC included.
Follow BHIC freePrice
BHIC price chart and AI forecast
Cross-section · 2026-10-16
How BHIC ranks among 5184 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Fundamentals · 2026-06-30
Bioscience Health Innovations, Inc. (BHIC) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Services-Computer Processing & Data Preparation peers listed below that report each metric.
Valuation & Market
| Metric | BHIC | Rank |
|---|---|---|
| Market Cap | $80M | 53/60 |
| P/B Ratio | 43.42x | 4/47 |
| EPS | $0.00 | – |
| Book Value/Share | $0.16 | – |
| Revenue/Share | $0.38 | – |
Profitability & Margins
| Metric | BHIC | Rank |
|---|---|---|
| ROE | -35.9% | 25/31 |
| ROA | -30.8% | 28/33 |
| Gross Margin | 53.8% | 26/41 |
| Operating Margin | -13.7% | 32/46 |
| Net Margin | -14.7% | 23/33 |
| EBT Margin | -13.7% | 32/47 |
| Tax Rate | -7.3% | – |
Financial Health
| Metric | BHIC | Rank |
|---|---|---|
| D/E Ratio | 0.16x | 41/51 |
| Financial Leverage | 1.16x | 36/45 |
| Interest Coverage | -9.2x | 35/44 |
Cash Flow
| Metric | BHIC | Rank |
|---|---|---|
| Operating Cash Flow | -$2M | 39/49 |
| OCF Growth YoY | -349.5% | 31/31 |
Operational Efficiency
| Metric | BHIC | Rank |
|---|---|---|
| Asset Turnover | 2.10x | 3/33 |
| Receivables Turnover | 11.3x | 9/35 |
| Inventory Turnover | 2.6x | 9/10 |
| Days Sales Outstanding | 32 days | 27/35 |
| Days Inventory | 140 days | 2/10 |
| Payables Period | 2 days | 29/29 |
| Cash Conversion Cycle | 171 days | 1/6 |
Income Statement
| Metric | BHIC | Rank |
|---|---|---|
| Total Revenue | $4M | 37/38 |
| Operating Income | -$610K | 31/48 |
| Net Income | -$660K | 22/35 |
| R&D Expense | $230K | 33/33 |
| SG&A Expense | $2M | 43/43 |
| Cost of Goods Sold | $2M | 41/42 |
Dividend & Shareholder Information
| Metric | BHIC | Rank |
|---|---|---|
| Shares Outstanding | 12M | – |
| Net Income Growth | -169.2% | 19/21 |
| EPS Growth | -100.0% | 22/24 |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $2M | 93.2% of assets |
| Cash & Short-term Investments | $710K | 33.3% of assets |
| Accounts Receivable | $400K | 18.7% of assets |
| Inventory | $800K | 37.5% of assets |
| Total Liabilities | $300K | 14.1% of assets |
Quarterly Financial Reports
BHIC quarterly financials and insider trading
Industry Peers · Services-Computer Processing & Data Preparation
Bioscience Health Innovations, Inc. (BHIC) industry peers
Companies classified under the same SEC industry code as Bioscience Health Innovations, Inc. (Services-Computer Processing & Data Preparation): 60 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| BHIC Bioscience Health Innovations, Inc. | ▶ | $80M |
| ADP Automatic Data Processing Inc | ▼ | $114.77B |
| WDAY Workday, Inc. | ▲ | $45.99B |
| RDDT Reddit, Inc. | ▲ | $29.97B |
| VRSK Verisk Analytics, Inc. | ▼ | $26.61B |
| TOST Toast, Inc. | ▶ | $18.28B |
| HNGE Hinge Health, Inc. | ▲ | $8.00B |
| RNG Ringcentral, Inc. | ▲ | $6.30B |
| BILI Bilibili Inc. | ▼ | $5.88B |
| PEGA Pegasystems Inc | ▲ | $5.68B |
| APLD Applied Digital Corp. | ▶ | $5.26B |
| QBTS D-Wave Quantum Inc. | ▼ | $4.35B |
| JOYY Joyy Inc. | ▼ | $4.21B |
| LIF Life360, Inc. | ▲ | $3.35B |
| FA First Advantage Corp | ▶ | $3.29B |
| LFTO Liftoff Mobile, Inc. | ▼ | $2.80B |
| CARG Cargurus, Inc. | ▲ | $2.70B |
| FIVN Five9, Inc. | ▲ | $2.41B |
| ATHM Autohome Inc. | ▶ | $2.40B |
| RAMP Liveramp Holdings, Inc. | ▼ | $2.28B |
| DXC Dxc Technology Co | ▶ | $2.18B |
| INFQ Infleqtion, Inc. | ▼ | $1.93B |
| EVTC Evertec, Inc. | ▶ | $1.86B |
| INOD Innodata Inc | ▲ | $1.82B |
| GLOB Globant S.A. | ▲ | $1.73B |
| HAWK Hawkeye 360, Inc. | ▼ | $1.22B |
| CLVT Clarivate Plc | ▲ | $1.17B |
| GDRX Goodrx Holdings, Inc. | ▲ | $1.15B |
| UPWK Upwork, Inc | ▲ | $1.05B |
| LZ Legalzoom.Com, Inc. | ▶ | $1.04B |
| SHAZ Sharonai Holdings Inc. | ▼ | $952M |
| PLTK Playtika Holding Corp. | ▲ | $805M |
| TASK Taskus, Inc. | ▲ | $754M |
| BRUN Boost Run Inc. | ▼ | $707M |
| DDI Doubledown Interactive Co., Ltd. | ▼ | $684M |
| YEXT Yext, Inc. | ▶ | $683M |
| NRDS Nerdwallet, Inc. | ▲ | $640M |
| IBEX Ibex Ltd | ▶ | $606M |
| SOPH Sophia Genetics Sa | ▲ | $573M |
| CARS Cars.Com Inc. | ▲ | $547M |
| OOMA Ooma Inc | ▲ | $544M |
| GRVY Gravity Co., Ltd. | ▼ | $464M |
| EGHT 8x8 Inc /De/ | ▲ | $280M |
| TRVG Trivago N.V. | ▲ | $280M |
| GLOO Gloo Holdings, Inc. | ▲ | $280M |
| MOVE Corvex, Inc. | ▼ | $254M |
| FCCN Spectral Capital Corp | ▲ | $221M |
| FIRY Firy Inc. | ▲ | $191M |
| AIAI Aiai Holdings Corp | ▼ | $189M |
| SSTK Shutterstock, Inc. | ▲ | $164M |
| TRAK Repositrak, Inc. | ▶ | $131M |
| QMLS Qumulusai, Inc. | ▼ | $127M |
| TCX Tucows Inc /Pa/ | ▲ | $114M |
| VERI Veritone, Inc. | ▶ | $54M |
| DTCX Datacentrex, Inc. | ▼ | $51M |
| CAST Freecast, Inc. | ▼ | $50M |
| PHUN Phunware, Inc. | ▶ | $42M |
| SJ Scienjoy Holding Corp | ▲ | $38M |
| DGNX Diginex Ltd | ▼ | $34M |
| GMHS Gamehaus Holdings Inc. | ▲ | $34M |
Where BHIC sits on the market map
Technology · Services-Computer Processing & Data Preparation
News
Bioscience Health Innovations, Inc. (BHIC) stock news
BioScience Health Innovations Inc Ordinary Shares BHIC
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Daré Bioscience, Inc. (DARE) Discusses Women's Health Portfolio and Commercialization Highlights on Virtual Bus Tour Transcript
Hello, and thank you for joining the Daré Bioscience's Virtual Bus Tour. My name is Justin Romanowski, Managing Director of JTC IR, and I'll be the moderator for today's event. Today, the company will ...
FAQ
Bioscience Health Innovations, Inc. (BHIC) stock forecast FAQ
What is the Bioscience Health Innovations, Inc. (BHIC) stock forecast?
On Oct. 16, 2026, BHIC is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5184 stocks scored that day.
How accurate are Bioscience Health Innovations, Inc. stock predictions?
For BHIC, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 25.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 32.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Bioscience Health Innovations, Inc. forecasts updated?
Bioscience Health Innovations, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Bioscience Health Innovations, Inc.'s industry peers?
60 issuers in our coverage, BHIC included, share the SEC industry code Services-Computer Processing & Data Preparation. The largest are: Automatic Data Processing Inc (ADP), Workday, Inc. (WDAY), Reddit, Inc. (RDDT), Verisk Analytics, Inc. (VRSK), Toast, Inc. (TOST), Hinge Health, Inc. (HNGE).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.